Plus Therapeutics, Inc.
Plus Therapeutics, Inc. (PSTV) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · PSTV · as of Jun 9, 2026
Activity summary
Buy transactions
2
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
Plus Therapeutics, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
PSTV insider buying and selling by quarter
PSTV insider selling · PSTV insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · PSTV ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
PSTV executive sell shares · PSTV board member insider trading · PSTV insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Apr 1, 2026 | Sims Andrew John Hugh MacIntyre CFO | Option | 29,129 | — | Form 4 |
| Apr 1, 2026 | Sims Andrew John Hugh MacIntyre CFO | Option | 38,323 | — | Form 4 |
| Apr 1, 2026 | HEDRICK MARC H CEO · Director | Option | 201,632 | — | Form 4 |
| Apr 1, 2026 | HEDRICK MARC H CEO · Director | Option | 159,681 | — | Form 4 |
| Jan 1, 2026 | HEDRICK MARC H CEO · Director | Option | 159,681 | — | Form 4 |
| Jan 1, 2026 | Sims Andrew John Hugh MacIntyre CFO | Option | 38,323 | — | Form 4 |
| Nov 4, 2025 | Sims Andrew John Hugh MacIntyre CFO | Purchase | 20,000 | $10K | Form 4 |
| Oct 1, 2025 | HEDRICK MARC H CEO · Director | Option | 159,681 | — | Form 4 |
| Oct 1, 2025 | Sims Andrew John Hugh MacIntyre CFO | Option | 38,323 | — | Form 4 |
| Aug 22, 2025 | Lenk Robert P Director | Purchase | 110,000 | $54K | Form 4 |
| Sep 13, 2024 | Hawkins Richard J Director | Purchase | 4,000 | $6K | Form 4 |
| Sep 12, 2024 | Hawkins Richard J Director | Purchase | 6,285 | $9K | Form 4 |
| Sep 11, 2024 | Petersen Greg Director | Purchase | 12,500 | $17K | Form 4 |
| Sep 11, 2024 | Clowes Howard Director | Purchase | 5,000 | $7K | Form 4 |
| Sep 10, 2024 | HEDRICK MARC H CEO · Director | Purchase | 8,000 | $10K | Form 4 |
| Sep 10, 2024 | Sims Andrew John Hugh MacIntyre CFO | Purchase | 4,098 | $5K | Form 4 |
| May 8, 2024 | Sims Andrew John Hugh MacIntyre CFO | Purchase | 4,902 | $10K | Form 4 |
| May 8, 2024 | HEDRICK MARC H CEO · Director | Purchase | 12,255 | $25K | Form 4 |
| May 8, 2024 | Petersen Greg Director | Purchase | 12,255 | $25K | Form 4 |
| May 8, 2024 | Clowes Howard Director | Purchase | 9,804 | $20K | Form 4 |
| May 8, 2024 | Hawkins Richard J Director | Purchase | 4,902 | $10K | Form 4 |
| May 8, 2024 | Lenk Robert P Director | Purchase | 4,167 | $9K | Form 4 |
| Nov 20, 2023 | HEDRICK MARC H CEO · Director | Sale | 2,068 | $4K | Form 4 |
| Nov 16, 2023 | Lenk Robert P Director | Purchase | 1,000 | $2K | Form 4 |
| Nov 15, 2023 | Lenk Robert P Director | Purchase | 1,000 | $2K | Form 4 |
Sims Andrew John Hugh MacIntyre
CFO
Date
Nov 4
Shares
20,000
Price
$0.51
Value
$10K
Sims Andrew John Hugh MacIntyre
CFO
Date
Sep 10
Shares
4,098
Price
$1.27
Value
$5K
Sims Andrew John Hugh MacIntyre
CFO
Date
May 8
Shares
4,902
Price
$2.04
Value
$10K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About PSTV insider trading
PSTV insider trades
Plus Therapeutics, Inc. (PSTV) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Sims Andrew John Hugh MacIntyre (CFO), HEDRICK MARC H (CEO · Director), Lenk Robert P (Director). Over the past 12 months, 3 insiders have filed transactions with the SEC. PSTV insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Plus Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
PSTV insider trading · 5 questionsThe insiders of Plus Therapeutics, Inc. (PSTV) include executives and directors such as Sims Andrew John Hugh MacIntyre (CFO), HEDRICK MARC H (CEO · Director), Lenk Robert P (Director), among others. Over the past 12 months, 3 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026